61 reports of this reaction
3.0% of all ASPIRIN LOW DOSE reports
#3 most reported adverse reaction
PNEUMONIA is the #3 most commonly reported adverse reaction for ASPIRIN LOW DOSE, manufactured by AARNA USA INC.. There are 61 FDA adverse event reports linking ASPIRIN LOW DOSE to PNEUMONIA. This represents approximately 3.0% of all 2,041 adverse event reports for this drug.
Patients taking ASPIRIN LOW DOSE who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is a less commonly reported adverse event for ASPIRIN LOW DOSE, but still significant enough to appear in the safety profile.
In addition to pneumonia, the following adverse reactions have been reported for ASPIRIN LOW DOSE:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 61 FDA reports for ASPIRIN LOW DOSE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 3.0% of all adverse event reports for ASPIRIN LOW DOSE, making it one of the most commonly reported side effect.
If you experience pneumonia while taking ASPIRIN LOW DOSE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.